Related Experiment Video
Updated: Sep 2, 2025
10:36
A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
14.4K
[High-flow nasal oxygen in acute hypoxemic respiratory failure]
M Rodriguez1, F Arrivé1, A W Thille2
1Médecine intensive réanimation, CHU de Poitiers, Poitiers, France.
Revue Des Maladies Respiratoires
|August 2, 2022
Summary
High-flow nasal oxygen therapy is increasingly used for acute hypoxemic respiratory failure due to ease of use and improved oxygenation. Further research is needed to confirm its survival benefits, especially in severe cases.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Respiratory Physiology
Background:
- Standard oxygen is first-line for acute hypoxemic respiratory failure.
- High-flow nasal oxygen (HFNO) is popular in ICUs for its simplicity, patient comfort, and oxygenation efficiency.
- HFNO may mitigate physiological consequences and reduce inspiratory efforts in patients.
Purpose of the Study:
- To evaluate the role and benefits of HFNO in acute hypoxemic respiratory failure.
- To compare the efficiency of different non-invasive oxygenation supports.
- To highlight the need for severity classification in acute hypoxemic respiratory failure.
Main Methods:
- Review of clinical studies comparing HFNO with conventional oxygen therapy.
- Analysis of physiological effects of HFNO.
- Discussion of existing evidence and future research directions.
Main Results:
- Clinical studies suggest HFNO may decrease the risk of intubation compared to conventional oxygen therapy.
- The benefits of HFNO regarding patient survival remain uncertain.
- A precise definition and severity classification of acute hypoxemic respiratory failure are needed for better comparisons.
Conclusions:
- HFNO offers advantages in managing acute hypoxemic respiratory failure, but survival benefits require further investigation.
- More clinical trials are essential to confirm the place of HFNO, particularly in severe cases.
- Standardized definitions and severity grading are crucial for comparing non-invasive oxygenation strategies.
Related Concept Videos
01:21Acute Respiratory Failure-II
336
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
336
01:21Acute Respiratory Failure-I
298
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
298
01:29Acute Respiratory Failure-V
191
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
191
01:23Acute Respiratory Failure-IV
211
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
211
01:26Oxygen Delivering System I: Nasal Cannula and Face Mask
559
The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
559
01:30Acute Respiratory Failure-III
301
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
301